title: A relaxometric method for the assessment of intestinal permeability based on the oral administration of gadolinium-based MRI contrast agents.
abstract: Herein, a new relaxometric method for the assessment of intestinal permeability based on the oral administration of clinically approved gadolinium (Gd)-based MRI contrast agents (CAs) is proposed. The fast, easily performed and cheap measurement of the longitudinal water proton relaxation rate (R1) in urine reports the amount of paramagnetic probe that has escaped the gastrointestinal tract. The proposed method appears to be a compelling alternative to the available methods for the assessment of intestinal permeability. The method was tested on the murine model of dextran sulfate sodium (DSS)-induced colitis in comparison with healthy mice. Three CAs were tested, namely ProHance®, MultiHance® and Magnevist®. Urine was collected for 24 h after the oral ingestion of the Gd-containing CA at day 3-4 (severe damage stage) and day 8-9 (recovery stage) after treatment with DSS. The Gd content in urine measured by (1)H relaxometry was confirmed by inductively coupled plasma-mass spectrometry (ICP-MS). The extent of urinary excretion was given as a percentage of excreted Gd over the total ingested dose. The method was validated by comparing the results obtained with the established methodology based on the lactulose/mannitol and sucralose tests. For ProHance and Magnevist, the excreted amounts in the severe stage of damage were 2.5-3 times higher than in control mice. At the recovery stage, no significant differences were observed with respect to healthy mice. Overall, a very good correlation with the lactulose/mannitol and sucralose results was obtained. In the case of MultiHance, the percentage of excreted Gd complex was not significantly different from that of control mice in either the severe or recovery stages. The difference from ProHance and Magnevist was explained on the basis of the (known) partial biliary excretion of MultiHance in mice.
authors: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
authors: Eliana
authors: E
authors: Gianolio
authors: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
authors: Cinzia
authors: C
authors: Boffa
authors: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
authors: Valeria
authors: V
authors: Orecchia
authors: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
authors: Paola
authors: P
authors: Bardini
authors: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
authors: Valeria
authors: V
authors: Catanzaro
authors: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
authors: Valeria
authors: V
authors: Poli
authors: Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
authors: Silvio
authors: S
authors: Aime
mesh_terms: D000284:Administration, Oral; D000818:Animals; D003092:Colitis / Q000473:pathology; D003106:Colon / Q000473:pathology; D003287:Contrast Media / Q000008:administration & dosage*; D016264:Dextran Sulfate; D004195:Disease Models, Animal; D005682:Gadolinium / Q000008:administration & dosage*; D007422:Intestines / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008807:Mice, Inbred BALB C; D010539:Permeability; D015203:Reproducibility of Results
chemical_list: D003287:Contrast Media; D016264:Dextran Sulfate; D005682:Gadolinium
keywords: Gd chelate-based contrast agents; colitis; gastrointestinal; intestinal permeability; relaxometry